Detalhe da pesquisa
1.
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity.
Gynecol Oncol
; 183: 61-67, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518529
2.
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 24(3): 286-296, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052965
3.
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study.
Future Oncol
; 16(27): 2059-2073, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32598185
4.
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.
Int J Gynecol Cancer
; 30(11): 1672-1677, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998859
5.
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy.
Future Oncol
; 14(9): 849-859, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29527957
6.
Measures of outcome in metastatic breast cancer: insights from a real-world scenario.
Oncologist
; 19(6): 608-15, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24794159
7.
How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature.
Front Oncol
; 14: 1335196, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38525421
8.
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.
J Clin Oncol
; 42(13): 1488-1498, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315944
9.
Is It Time to Reassess the Role of Radiotherapy Treatment in Ovarian Cancer?
Healthcare (Basel)
; 11(17)2023 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37685447
10.
A Rare Case of Hepatocellular Carcinoma Recurrence in Ovarian Site after 12 Years Mimicking a Hepatoid Adenocarcinoma: Case Report.
J Clin Med
; 12(7)2023 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37048552
11.
Management of Patients Diagnosed with Endometrial Cancer: Comparison of Guidelines.
Cancers (Basel)
; 15(4)2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831434
12.
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.
Cancers (Basel)
; 15(4)2023 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831376
13.
Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy.
Anticancer Drugs
; 23(3): 326-34, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22129512
14.
Survivin, sonic hedgehog, krüppel-like factors, and p53 pathway in serous ovarian cancer: an immunohistochemical study.
Hum Pathol
; 127: 92-101, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777700
15.
Mesonephric-Like Adenocarcinomas a Rare Tumor: The Importance of Diagnosis.
Int J Environ Res Public Health
; 19(21)2022 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36361332
16.
CUP-syndrome: Inguinal high grade serous ovarian carcinoma lymph node metastases with unknown primary origin - a case report and literature review.
Front Oncol
; 12: 987169, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300091
17.
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
Front Oncol
; 12: 885992, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747814
18.
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial.
Eur J Cancer
; 154: 21-29, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34225066
19.
Extraskeletal myxoid chondrosarcoma: a case report with adjuvant intraoperative treatment.
J Surg Case Rep
; 2020(12): rjaa503, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33391642
20.
Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era.
Anticancer Drugs
; 20(6): 503-7, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19339872